By Kat Greene ( September 12, 2013, 11:05 PM EDT) -- Eli Lilly & Co. launched a $500 million assault on Canadian patent law Thursday with a notice of arbitration challenging the Canadian government's so-called promise doctrine, saying it unfairly discriminates against pharmaceutical companies in violation of a North American Free Trade Agreement rule....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.